GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Tangible Book per Share

Dian Diagnostics Group Co (SZSE:300244) Tangible Book per Share : ¥10.50 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Tangible Book per Share?

Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. Dian Diagnostics Group Co's tangible book value per share for the quarter that ended in Mar. 2024 was ¥10.50.

Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


Dian Diagnostics Group Co Tangible Book per Share Historical Data

The historical data trend for Dian Diagnostics Group Co's Tangible Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Tangible Book per Share Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tangible Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.57 5.40 7.28 10.48 10.60

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tangible Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.42 10.78 11.06 10.60 10.50

Competitive Comparison of Dian Diagnostics Group Co's Tangible Book per Share

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Price-to-Tangible-Book falls into.



Dian Diagnostics Group Co Tangible Book per Share Calculation

Dian Diagnostics Group Co's Tangible Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(7566.265-0-918.379)/626.898
=10.60

Dian Diagnostics Group Co's Tangible Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(7497.593-0-915.686)/626.898
=10.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


Dian Diagnostics Group Co  (SZSE:300244) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Dian Diagnostics Group Co Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines